Join us for the third webinar from the IAA Clinical Trials team that will focus on the FDA’s Expanded Access Program and how it might help people living with ALS. Join Dan McIntyre, co-chair of the IAA Clinical Trials Team, Troy Fields, co-chair of the IAA Legislative Affairs Team and living with ALS, and Sonya Elling, IAA Chief Government Affairs Officer, to learn more about the mechanics of Expanded Access and how the ACT for ALS has played an important role in expanding access to investigational drugs for ALS patients.

Join us on Tuesday, October 8 at 7pm ET!